2-(3,4-DIhydro-2h-1,5-benzodioxepin-7-yl)acetic acid

Catalog No.: 
ACAQXV664
CAS No.: 
127264-07-7
Molecular Formula: 
C11H12O4
Molecular Weight: 
208.21
2-(3,4-DIhydro-2h-1,5-benzodioxepin-7-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$104.00InquiryInquiry
100mg95%$148.00InquiryInquiry
250mg95%$203.00InquiryInquiry
1g95%$393.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3,4-DIhydro-2h-1,5-benzodioxepin-7-yl)acetic acid
IUPAC Name2-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)acetic acid
MDL No.MFCD01790620
Molecular FormulaC11H12O4
Molecular Weight208.21
SMILESOC(CC1=CC2=C(C=C1)OCCCO2)=O
InChI KeyCQJUSOWHUIENHK-UHFFFAOYSA-N
Synonym3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YLACETIC ACID;AKOS BBS-00005952;(3,4-Dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-acetic acid;TIMTEC-BB SBB011191;2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetic acid;2H-1,5-Benzodioxepin-7-acetic acid, 3,4-dihydro-
CAS No.127264-07-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAQXV664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAQXV664 route product structure diagram
    ACAQXV664127264-07-7
Inquiry

2. ACAQXV664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAQXV664 route product structure diagram
    ACAQXV664127264-07-7
Inquiry

3. ACAQXV664 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAQXV664 route product structure diagram
    ACAQXV664127264-07-7
Inquiry

Comments (0)